The stock is in a sustained, volatile uptrend, evidenced by a staggering 329.58% one-year price change, but is currently trading in a consolidation phase. With a current price of $84.8, it sits approximately 85% of the way up from its 52-week low of $18.21 toward its high of $99.58, indicating it is trading near the upper end of its annual range, which reflects strong momentum but also potential for overextension. Recent momentum shows a significant divergence, with a strong 22.05% gain over the past month sharply contrasting with a -11.94% loss over the past three months, suggesting the stock is recovering from a sharp pullback and attempting to re-establish its longer-term uptrend. The stock's beta of 2.205 indicates it is over 120% more volatile than the broader market, which is critical for risk assessment, with key technical support at the recent March low near $57.38 and major resistance at the 52-week high of $99.58; a breakout above resistance would signal a resumption of the powerful uptrend, while a breakdown below $57 could indicate a deeper correction.

Revenue growth is robust and accelerating, with Q4 2025 revenue of $179.65 million representing a 35.7% year-over-year increase, and the sequential trend from Q1 ($122.57M) to Q4 shows consistent quarterly growth. The company remains unprofitable, with a Q4 net income of -$52.92 million, but there is a notable improvement in net margin from -49.5% in Q1 to -29.5% in Q4, while gross margin expanded to 37.98% in Q4 from 28.76% in Q1, indicating progress on the path to profitability. The balance sheet shows a strong liquidity position with a current ratio of 4.08 and a low debt-to-equity ratio of 0.147, but cash flow remains a critical watchpoint as the company reported negative free cash flow of -$114.19 million for Q4 and a trailing twelve-month FCF of -$321.81 million, indicating it is still heavily reliant on external financing to fund its growth and capital expenditures.